JPH0573729B2 - - Google Patents

Info

Publication number
JPH0573729B2
JPH0573729B2 JP87116631A JP11663187A JPH0573729B2 JP H0573729 B2 JPH0573729 B2 JP H0573729B2 JP 87116631 A JP87116631 A JP 87116631A JP 11663187 A JP11663187 A JP 11663187A JP H0573729 B2 JPH0573729 B2 JP H0573729B2
Authority
JP
Japan
Prior art keywords
cholesterol
chloro
blood
hdl
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP87116631A
Other languages
English (en)
Japanese (ja)
Other versions
JPS63107926A (ja
Inventor
Koki Takashima
Tetsuji Mori
Hiroshi Nagao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of JPS63107926A publication Critical patent/JPS63107926A/ja
Publication of JPH0573729B2 publication Critical patent/JPH0573729B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP62116631A 1986-05-16 1987-05-12 血中脂質改善剤 Granted JPS63107926A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11318286 1986-05-16
JP61-113182 1986-05-16

Publications (2)

Publication Number Publication Date
JPS63107926A JPS63107926A (ja) 1988-05-12
JPH0573729B2 true JPH0573729B2 (enExample) 1993-10-15

Family

ID=14605628

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62116631A Granted JPS63107926A (ja) 1986-05-16 1987-05-12 血中脂質改善剤

Country Status (10)

Country Link
US (1) US4778791A (enExample)
EP (1) EP0246573B1 (enExample)
JP (1) JPS63107926A (enExample)
AT (1) ATE80036T1 (enExample)
DE (1) DE3781456T2 (enExample)
DK (1) DK248987A (enExample)
FR (1) FR2598618B1 (enExample)
GB (1) GB2190290B (enExample)
HK (1) HK7993A (enExample)
SG (1) SG60192G (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786634A (en) * 1986-05-23 1988-11-22 Tanabe Seikyaku Co., Ltd. Method for treating arteriosclerosis
IL108634A0 (en) * 1993-02-15 1994-05-30 Wellcome Found Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them
US5674488A (en) * 1994-10-07 1997-10-07 Reich; John J. Method for prevention and treatment of hyperchlolesterolemia by in vivo hydrogenation of cholesterol
US6354765B2 (en) 2000-02-15 2002-03-12 Exxonmobile Upstream Research Company Method of transporting and disposing of an offshore platform jacket

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59157021A (ja) * 1983-02-25 1984-09-06 Tanabe Seiyaku Co Ltd 動脈硬化症予防治療剤
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
GB8315364D0 (en) * 1983-06-03 1983-07-06 Tanabe Seiyaku Co 8-chloro-1 5-benzothiazepine derivatives
JPS59231018A (ja) * 1983-06-10 1984-12-25 Tanabe Seiyaku Co Ltd 抗脂血剤

Also Published As

Publication number Publication date
DE3781456D1 (de) 1992-10-08
GB2190290B (en) 1990-01-04
US4778791A (en) 1988-10-18
EP0246573A3 (en) 1990-01-31
GB2190290A (en) 1987-11-18
EP0246573B1 (en) 1992-09-02
ATE80036T1 (de) 1992-09-15
GB8711407D0 (en) 1987-06-17
FR2598618A1 (fr) 1987-11-20
EP0246573A2 (en) 1987-11-25
DK248987A (da) 1987-11-17
SG60192G (en) 1993-04-16
JPS63107926A (ja) 1988-05-12
FR2598618B1 (fr) 1991-10-25
DK248987D0 (da) 1987-05-14
HK7993A (en) 1993-02-12
DE3781456T2 (de) 1993-03-18

Similar Documents

Publication Publication Date Title
JP2002537258A5 (enExample)
TWI225399B (en) Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders
JPH0573729B2 (enExample)
US4822789A (en) Method of producing renal function-improving effect and diuretic effect on warm-blooded animal
US4806530A (en) Pharmaceutical compositions based on diltiazem and lysine acetylsalicylate
US5387581A (en) Pharmaceutical composition of aspirin and a benzothiazepine for inhibiting platelet aggregation
US20080108597A1 (en) New Use of Quetiapine
KR920003579B1 (ko) 혈중 지질 조성을 개선시키기 위한 제약 조성물
CA2112195A1 (en) Preventive and therapeutic agent for arteriosclerosis
JPS6317045B2 (enExample)
US4414212A (en) Method of treatment of pre-menstrual syndrome
JPS6317044B2 (enExample)
JPH0119A (ja) 腎機能改善剤
JPH0737388B2 (ja) 腎機能改善剤
JP2658783B2 (ja) 抗動脈硬化剤
JPS59231018A (ja) 抗脂血剤
JPS63107925A (ja) 動脈硬化症予防・治療剤
JPH078798B2 (ja) 血小板凝集抑制組成物
KR920003580B1 (ko) 동맥경화증 예방 및 치료제
JPH078799B2 (ja) 血小板凝集抑制組成物
JP2712143B2 (ja) 血小板凝集抑制組成物
JPH06102624B2 (ja) 非心臓由来の不整脈防止薬
JPH0421667B2 (enExample)
JPH06135834A (ja) 赤血球変形能改善剤
JPH078791B2 (ja) ジベンズ〔ｃｄ，ｆ〕インド−ルの新規用途